Clinical TrialsSearch results
Number of results: 2446
Recruiting
- Tranlational Research: A Phase I study of Oxyfedrine and Sulfasalazine in Patients with Solid Tumor
- unresectable recurrent solid tumor
- Shitara Kohei
- 2023-12-22
Recruiting
- A Randomized Controlled Study of Suizenji in Patients with Unresectable Pancreatic Cancer
- Unresectable pancreatic cancer
- Iwasaki Seinori
- 2022-10-29
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Recruiting
- JCOG1901: An intergroup phase III study of combination therapy with everolimus and lanreotide versus everolimus monotherapy for unresectable or recurrent gastroenteropancreatic neuroendocrine tumor
- Unresectable or reccurent gastroenteropancreatic neuroendocrine tumor.
- MIZUNO Nobumasa
- 2020-04-27
Recruiting
- [M24-311]Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
- unresectable metastatic colorectal cancer
- Yamagishi Chika
- 2023-11-10
Other
- A phase I/II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0203)
- Unresectable malignant lung tumor.
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-06
Other
- Phase II trial of chemoradiotherapy concurrent with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck (JCOG0706)
- unresectable locally advanced squamous cell carcinoma of the head and neck
- Japan Clinical Oncology Group (JCOG)
- 2008-07-28
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from URLC10:a phase I study in patient with unresectable esophageal cancer
- unresectable esophageal cancer
- Institute of Medical Science The University of Tokyo
- 2007-12-24
Recruiting
- ONO-4578-02:ONO-4578 Phase 1 Study
- Unresectable colorectal cancer
- Hirashima Yoshinori
- 2020-11-25